Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,890
Closed -$387K 192
2025
Q2
$387K Sell
4,890
-4,800
-50% -$382K 0.09% 160
2025
Q1
$870K Sell
9,690
-8,310
-46% -$776K 0.2% 145
2024
Q4
$1.79M Buy
18,000
+1,900
+12% +$196K 0.4% 101
2024
Q3
$1.83M Hold
16,100
0.38% 102
2024
Q2
$2.06M Hold
16,100
0.46% 97
2024
Q1
$2.11M Hold
16,100
0.46% 93
2023
Q4
$1.76M Hold
16,100
0.4% 103
2023
Q3
$1.66M Hold
16,100
0.41% 101
2023
Q2
$1.86M Hold
16,100
0.47% 92
2023
Q1
$1.71M Buy
+16,100
New +$1.74M 0.44% 96
2020
Q3
Sell
-27,458
Closed -$2.03M 217
2020
Q2
$2.03M Sell
27,458
-53,330
-66% -$4.01M 0.4% 93
2020
Q1
$5.93M Hold
80,788
1.29% 15
2019
Q4
$7.01M Sell
80,788
-5,974
-7% -$491K 1% 22
2019
Q3
$6.97M Sell
86,762
-13,205
-13% -$1.06M 1.03% 16
2019
Q2
$8M Buy
99,967
+7,441
+8% +$570K 0.75% 38
2019
Q1
$7.34M Buy
92,526
+20,017
+28% +$1.5M 0.74% 39
2018
Q4
$5.29M Sell
72,509
-5,881
-8% -$415K 0.56% 54
2018
Q3
$5.31M Sell
78,390
-8,594
-10% -$548K 0.45% 67
2018
Q2
$5.04M Sell
86,984
-31,021
-26% -$1.75M 0.38% 77
2018
Q1
$6.13M Buy
118,005
+13,415
+13% +$725K 0.46% 70
2017
Q4
$5.62M Sell
104,590
-2,725
-3% -$151K 0.39% 75
2017
Q3
$6.56M Hold
107,315
0.46% 72
2017
Q2
$6.56M Sell
107,315
-12,367
-10% -$753K 0.46% 71
2017
Q1
$7.26M Buy
+119,682
New +$7.26M 0.5% 62
2016
Q4
Sell
-10,794
Closed -$643K 436
2016
Q3
$643K Sell
10,794
-36,261
-77% -$2.12M 0.04% 341
2016
Q2
$2.59M Sell
47,055
-22,008
-32% -$1.17M 0.18% 167
2016
Q1
$3.49M Hold
69,063
0.25% 140
2015
Q4
$3.48M Buy
69,063
+17,711
+34% +$893K 0.24% 133
2015
Q3
$2.42M Sell
51,352
-32,488
-39% -$1.73M 0.17% 149
2015
Q2
$4.55M Hold
83,840
0.29% 105
2015
Q1
$4.6M Hold
83,840
0.27% 111
2014
Q4
$4.54M Buy
+83,840
New +$4.67M 0.27% 111

Other funds holding MRK

Icon Advisers's MRK Position: Q3 2025 in Review

Icon Advisers sold out of Merck (MRK) in Q3 2025, closing a stake of 4,890 shares — an estimated $387K sold.

Icon Advisers first reported a position in MRK in Q4 2014 and held it in 32 quarters. The position peaked at $8M in Q2 2019. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Icon Advisers reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • Icon Advisers sold 4,890 Merck shares in Q3 2025, an estimated $387K.
  • Icon Advisers first reported a position in Merck in Q4 2014 and held it in 32 quarters.
  • Icon Advisers's Merck position peaked at $8M in Q2 2019.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Icon Advisers's 13F filing for Q3 2025, filed 12 Nov 2025.